Quest Diagnostics Inc (DGX)
134.25
-1.17
(-0.86%)
USD |
NYSE |
Apr 26, 16:00
134.01
-0.24
(-0.18%)
After-Hours: 20:00
Quest Diagnostics Enterprise Value: 19.39B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 19.39B |
| April 24, 2024 | 19.63B |
| April 23, 2024 | 19.54B |
| April 22, 2024 | 18.80B |
| April 19, 2024 | 18.62B |
| April 18, 2024 | 18.34B |
| April 17, 2024 | 18.46B |
| April 16, 2024 | 18.51B |
| April 15, 2024 | 18.64B |
| April 12, 2024 | 18.62B |
| April 11, 2024 | 18.78B |
| April 10, 2024 | 18.96B |
| April 09, 2024 | 19.09B |
| April 08, 2024 | 18.78B |
| April 05, 2024 | 18.85B |
| April 04, 2024 | 18.95B |
| April 03, 2024 | 19.05B |
| April 02, 2024 | 19.03B |
| April 01, 2024 | 19.31B |
| March 31, 2024 | 19.13B |
| March 28, 2024 | 19.05B |
| March 27, 2024 | 18.82B |
| March 26, 2024 | 18.58B |
| March 25, 2024 | 18.62B |
| March 22, 2024 | 18.63B |
| Date | Value |
|---|---|
| March 21, 2024 | 18.57B |
| March 20, 2024 | 18.45B |
| March 19, 2024 | 18.60B |
| March 18, 2024 | 18.50B |
| March 15, 2024 | 18.47B |
| March 14, 2024 | 18.34B |
| March 13, 2024 | 18.59B |
| March 12, 2024 | 18.63B |
| March 11, 2024 | 18.60B |
| March 08, 2024 | 18.35B |
| March 07, 2024 | 18.37B |
| March 06, 2024 | 18.32B |
| March 05, 2024 | 18.05B |
| March 04, 2024 | 18.14B |
| March 01, 2024 | 18.07B |
| February 29, 2024 | 18.09B |
| February 28, 2024 | 18.18B |
| February 27, 2024 | 18.26B |
| February 26, 2024 | 18.24B |
| February 23, 2024 | 18.34B |
| February 22, 2024 | 18.14B |
| February 21, 2024 | 18.30B |
| February 20, 2024 | 17.97B |
| February 16, 2024 | 17.99B |
| February 15, 2024 | 18.19B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
13.64B
Minimum
Apr 03 2020
24.23B
Maximum
Dec 16 2021
19.18B
Average
19.21B
Median
May 05 2023
Enterprise Value Benchmarks
| Laboratory Corp of America Holdings | 21.21B |
| Exact Sciences Corp | 12.26B |
| Delcath Systems Inc | 111.51M |
| CytoSorbents Corp | 34.84M |
| Progyny Inc | 2.765B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 194.00M |
| Revenue (Quarterly) | 2.366B |
| Total Expenses (Quarterly) | 2.066B |
| EPS Diluted (Quarterly) | 1.72 |
| Gross Profit Margin (Quarterly) | 32.59% |
| Profit Margin (Quarterly) | 8.20% |
| Earnings Yield | 5.53% |
| Operating Earnings Yield | 8.29% |
| Normalized Earnings Yield | 5.534 |